CN115710199B - Photooxidation reduction catalytic process - Google Patents
Photooxidation reduction catalytic process Download PDFInfo
- Publication number
- CN115710199B CN115710199B CN202211378442.0A CN202211378442A CN115710199B CN 115710199 B CN115710199 B CN 115710199B CN 202211378442 A CN202211378442 A CN 202211378442A CN 115710199 B CN115710199 B CN 115710199B
- Authority
- CN
- China
- Prior art keywords
- alkyl
- tertiary alcohol
- free radical
- aryl
- linear tertiary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 54
- 230000003197 catalytic effect Effects 0.000 title claims abstract description 17
- 230000008569 process Effects 0.000 title claims description 13
- 238000007539 photo-oxidation reaction Methods 0.000 title abstract description 11
- 230000009467 reduction Effects 0.000 title abstract description 11
- -1 tertiary alcohol compound Chemical class 0.000 claims abstract description 99
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 46
- 150000003254 radicals Chemical class 0.000 claims abstract description 33
- 239000011941 photocatalyst Substances 0.000 claims abstract description 24
- 238000006555 catalytic reaction Methods 0.000 claims abstract description 21
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 28
- 125000003118 aryl group Chemical group 0.000 claims description 19
- 239000007848 Bronsted acid Substances 0.000 claims description 11
- 239000007800 oxidant agent Substances 0.000 claims description 11
- 229910052736 halogen Inorganic materials 0.000 claims description 10
- 150000002367 halogens Chemical class 0.000 claims description 10
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 10
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 claims description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 9
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 claims description 8
- 125000006735 (C1-C20) heteroalkyl group Chemical group 0.000 claims description 7
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 claims description 7
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims description 7
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 7
- 230000001590 oxidative effect Effects 0.000 claims description 7
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 6
- SMUQFGGVLNAIOZ-UHFFFAOYSA-N quinaldine Chemical compound C1=CC=CC2=NC(C)=CC=C21 SMUQFGGVLNAIOZ-UHFFFAOYSA-N 0.000 claims description 6
- IAEGWXHKWJGQAZ-UHFFFAOYSA-N trimethylpyrazine Chemical compound CC1=CN=C(C)C(C)=N1 IAEGWXHKWJGQAZ-UHFFFAOYSA-N 0.000 claims description 6
- 125000003358 C2-C20 alkenyl group Chemical group 0.000 claims description 5
- 239000003054 catalyst Substances 0.000 claims description 5
- 125000004404 heteroalkyl group Chemical group 0.000 claims description 5
- 125000003860 C1-C20 alkoxy group Chemical group 0.000 claims description 4
- 235000001258 Cinchona calisaya Nutrition 0.000 claims description 4
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 claims description 4
- 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 claims description 4
- 125000005103 alkyl silyl group Chemical group 0.000 claims description 4
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 claims description 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 4
- QEWYKACRFQMRMB-UHFFFAOYSA-N fluoroacetic acid Chemical group OC(=O)CF QEWYKACRFQMRMB-UHFFFAOYSA-N 0.000 claims description 4
- 229960000948 quinine Drugs 0.000 claims description 4
- LSBIUXKNVUBKRI-UHFFFAOYSA-N 4,6-dimethylpyrimidine Chemical compound CC1=CC(C)=NC=N1 LSBIUXKNVUBKRI-UHFFFAOYSA-N 0.000 claims description 3
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims description 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 3
- SNOLCJGSEPTCMD-UHFFFAOYSA-N ethyl 5-methyl-1,3-thiazole-4-carboxylate Chemical compound CCOC(=O)C=1N=CSC=1C SNOLCJGSEPTCMD-UHFFFAOYSA-N 0.000 claims description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 3
- 125000000027 (C1-C10) alkoxy group Chemical group 0.000 claims description 2
- XWKFPIODWVPXLX-UHFFFAOYSA-N 2-methyl-5-methylpyridine Natural products CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 claims description 2
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 claims description 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 2
- JRKICGRDRMAZLK-UHFFFAOYSA-L persulfate group Chemical group S(=O)(=O)([O-])OOS(=O)(=O)[O-] JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- FPQXSHYMJOHIED-UHFFFAOYSA-N trifluoromethyl sulfamate Chemical compound NS(=O)(=O)OC(F)(F)F FPQXSHYMJOHIED-UHFFFAOYSA-N 0.000 claims description 2
- HWRFTOWHSBECMR-UHFFFAOYSA-N 6-n-[(4-aminophenyl)methyl]-2-n-[[3-(trifluoromethyl)phenyl]methyl]-7h-purine-2,6-diamine Chemical compound C1=CC(N)=CC=C1CNC1=NC(NCC=2C=C(C=CC=2)C(F)(F)F)=NC2=C1NC=N2 HWRFTOWHSBECMR-UHFFFAOYSA-N 0.000 claims 1
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 claims 1
- 150000003509 tertiary alcohols Chemical class 0.000 abstract description 33
- 125000000217 alkyl group Chemical group 0.000 abstract description 28
- 238000004519 manufacturing process Methods 0.000 abstract description 10
- 239000011203 carbon fibre reinforced carbon Substances 0.000 abstract description 6
- 230000003647 oxidation Effects 0.000 abstract description 5
- 238000007254 oxidation reaction Methods 0.000 abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 4
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 47
- 239000000047 product Substances 0.000 description 46
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 23
- 238000005160 1H NMR spectroscopy Methods 0.000 description 23
- 125000005842 heteroatom Chemical group 0.000 description 23
- 238000004458 analytical method Methods 0.000 description 21
- 238000012512 characterization method Methods 0.000 description 21
- 238000006243 chemical reaction Methods 0.000 description 19
- 125000001072 heteroaryl group Chemical group 0.000 description 19
- 125000003342 alkenyl group Chemical group 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 14
- 229910052717 sulfur Chemical group 0.000 description 14
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 12
- 125000003545 alkoxy group Chemical group 0.000 description 12
- 229910052757 nitrogen Inorganic materials 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 11
- 150000002391 heterocyclic compounds Chemical group 0.000 description 9
- 238000006722 reduction reaction Methods 0.000 description 9
- 229910052799 carbon Inorganic materials 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 125000004433 nitrogen atom Chemical group N* 0.000 description 8
- 125000000304 alkynyl group Chemical group 0.000 description 7
- 125000005553 heteroaryloxy group Chemical group 0.000 description 7
- 125000002950 monocyclic group Chemical group 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 7
- 125000003367 polycyclic group Chemical group 0.000 description 7
- 239000002243 precursor Substances 0.000 description 7
- 125000003107 substituted aryl group Chemical group 0.000 description 7
- 239000011593 sulfur Chemical group 0.000 description 7
- 125000004434 sulfur atom Chemical group 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 6
- 229910052786 argon Inorganic materials 0.000 description 6
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 6
- 125000004104 aryloxy group Chemical group 0.000 description 6
- 125000004366 heterocycloalkenyl group Chemical group 0.000 description 6
- 150000002430 hydrocarbons Chemical group 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 239000000741 silica gel Substances 0.000 description 6
- 229910002027 silica gel Inorganic materials 0.000 description 6
- 125000001424 substituent group Chemical group 0.000 description 6
- ODFHXXQVNHHDDG-UHFFFAOYSA-N 2-benzylpropanedinitrile Chemical compound N#CC(C#N)CC1=CC=CC=C1 ODFHXXQVNHHDDG-UHFFFAOYSA-N 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 230000002950 deficient Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000003818 flash chromatography Methods 0.000 description 5
- 229930195733 hydrocarbon Natural products 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Chemical group 0.000 description 5
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 description 5
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 4
- 239000004215 Carbon black (E152) Substances 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 125000001931 aliphatic group Chemical group 0.000 description 4
- 150000001721 carbon Chemical group 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 125000004430 oxygen atom Chemical group O* 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 150000003212 purines Chemical class 0.000 description 4
- 150000003216 pyrazines Chemical class 0.000 description 4
- 150000003222 pyridines Chemical class 0.000 description 4
- 150000003230 pyrimidines Chemical class 0.000 description 4
- 239000000376 reactant Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 description 3
- 125000006649 (C2-C20) alkynyl group Chemical group 0.000 description 3
- 125000006651 (C3-C20) cycloalkyl group Chemical group 0.000 description 3
- HVYOVJPTWXVNKQ-UHFFFAOYSA-N 3,3-dimethyl-2-phenylbutan-2-ol Chemical compound CC(C)(C)C(C)(O)C1=CC=CC=C1 HVYOVJPTWXVNKQ-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Substances OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 3
- 239000000575 pesticide Substances 0.000 description 3
- 238000011913 photoredox catalysis Methods 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 125000003373 pyrazinyl group Chemical group 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 150000007979 thiazole derivatives Chemical class 0.000 description 3
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 2
- HWMJNDVUIMQFEW-UHFFFAOYSA-N 2,6-dichloro-9-methylpurine Chemical compound N1=C(Cl)N=C2N(C)C=NC2=C1Cl HWMJNDVUIMQFEW-UHFFFAOYSA-N 0.000 description 2
- RIWRBSMFKVOJMN-UHFFFAOYSA-N 2-methyl-1-phenylpropan-2-ol Chemical compound CC(C)(O)CC1=CC=CC=C1 RIWRBSMFKVOJMN-UHFFFAOYSA-N 0.000 description 2
- KGIGUEBEKRSTEW-UHFFFAOYSA-N 2-vinylpyridine Chemical compound C=CC1=CC=CC=N1 KGIGUEBEKRSTEW-UHFFFAOYSA-N 0.000 description 2
- KZVSJCRPDWUPEP-UHFFFAOYSA-N 3-methyl-2-phenylbutan-2-ol Chemical compound CC(C)C(C)(O)C1=CC=CC=C1 KZVSJCRPDWUPEP-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- 125000005915 C6-C14 aryl group Chemical group 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- WZKSXHQDXQKIQJ-UHFFFAOYSA-N F[C](F)F Chemical compound F[C](F)F WZKSXHQDXQKIQJ-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000005336 allyloxy group Chemical group 0.000 description 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 125000000298 cyclopropenyl group Chemical group [H]C1=C([H])C1([H])* 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 150000002240 furans Chemical group 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 239000012038 nucleophile Substances 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- 229940083251 peripheral vasodilators purine derivative Drugs 0.000 description 2
- 230000001699 photocatalysis Effects 0.000 description 2
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 2
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- 125000000168 pyrrolyl group Chemical group 0.000 description 2
- 230000027756 respiratory electron transport chain Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 125000000547 substituted alkyl group Chemical group 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 125000000335 thiazolyl group Chemical group 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 1
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 description 1
- 125000006526 (C1-C2) alkyl group Chemical group 0.000 description 1
- 125000006536 (C1-C2)alkoxy group Chemical group 0.000 description 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 1
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 description 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 description 1
- 125000006527 (C1-C5) alkyl group Chemical group 0.000 description 1
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 description 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- 125000006592 (C2-C3) alkenyl group Chemical group 0.000 description 1
- 125000006593 (C2-C3) alkynyl group Chemical group 0.000 description 1
- 125000006717 (C3-C10) cycloalkenyl group Chemical group 0.000 description 1
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 description 1
- 125000006645 (C3-C4) cycloalkyl group Chemical group 0.000 description 1
- 125000006555 (C3-C5) cycloalkyl group Chemical group 0.000 description 1
- 125000006655 (C3-C8) heteroaryl group Chemical group 0.000 description 1
- KABQEPJVQFXVIN-UHFFFAOYSA-N 1-(benzenesulfonyl)ethenylsulfonylbenzene Chemical group C=1C=CC=CC=1S(=O)(=O)C(=C)S(=O)(=O)C1=CC=CC=C1 KABQEPJVQFXVIN-UHFFFAOYSA-N 0.000 description 1
- 238000004293 19F NMR spectroscopy Methods 0.000 description 1
- CFNSRIIHFLPQCE-UHFFFAOYSA-N 2-(trifluoromethylsulfanyl)isoindole-1,3-dione Chemical group C1=CC=C2C(=O)N(SC(F)(F)F)C(=O)C2=C1 CFNSRIIHFLPQCE-UHFFFAOYSA-N 0.000 description 1
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 1
- NSFSAHIOBUAWGP-UHFFFAOYSA-N 2-n,2-n-diphenylbenzene-1,2-diamine Chemical compound NC1=CC=CC=C1N(C=1C=CC=CC=1)C1=CC=CC=C1 NSFSAHIOBUAWGP-UHFFFAOYSA-N 0.000 description 1
- XBIHZOVRMJOAEQ-UHFFFAOYSA-N 2-phenyl-2,3-dihydro-1h-perimidine Chemical compound N1C(C=23)=CC=CC3=CC=CC=2NC1C1=CC=CC=C1 XBIHZOVRMJOAEQ-UHFFFAOYSA-N 0.000 description 1
- 125000005914 C6-C14 aryloxy group Chemical group 0.000 description 1
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Divinylene sulfide Natural products C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 1
- YEWGIGCYIAMFMA-UHFFFAOYSA-N LSM-2007 Chemical compound C1C2=CC=CC=C2CCN(C)CCC2=C1NC1=CC=CC=C21 YEWGIGCYIAMFMA-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 1
- 125000002393 azetidinyl group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004619 benzopyranyl group Chemical group O1C(C=CC2=C1C=CC=C2)* 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 238000010504 bond cleavage reaction Methods 0.000 description 1
- 238000006664 bond formation reaction Methods 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000001047 cyclobutenyl group Chemical group C1(=CCC1)* 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 125000004415 heterocyclylalkyl group Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
- 150000002497 iodine compounds Chemical class 0.000 description 1
- 125000001977 isobenzofuranyl group Chemical group C=1(OC=C2C=CC=CC12)* 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- GQTXKEVAUZYHGE-UHFFFAOYSA-N methyl 2-phenylprop-2-enoate Chemical compound COC(=O)C(=C)C1=CC=CC=C1 GQTXKEVAUZYHGE-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- JPONLSOQEDZIOZ-UHFFFAOYSA-N n,n,2-trimethylnaphthalen-1-amine Chemical compound C1=CC=C2C(N(C)C)=C(C)C=CC2=C1 JPONLSOQEDZIOZ-UHFFFAOYSA-N 0.000 description 1
- RLKHFSNWQCZBDC-UHFFFAOYSA-N n-(benzenesulfonyl)-n-fluorobenzenesulfonamide Chemical compound C=1C=CC=CC=1S(=O)(=O)N(F)S(=O)(=O)C1=CC=CC=C1 RLKHFSNWQCZBDC-UHFFFAOYSA-N 0.000 description 1
- IZUQZLGWRCYWCB-UHFFFAOYSA-N n-[(4-methoxyphenyl)methylideneamino]aniline Chemical compound C1=CC(OC)=CC=C1C=NNC1=CC=CC=C1 IZUQZLGWRCYWCB-UHFFFAOYSA-N 0.000 description 1
- 125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- AZQWKYJCGOJGHM-UHFFFAOYSA-N para-benzoquinone Natural products O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 125000005981 pentynyl group Chemical group 0.000 description 1
- 239000012450 pharmaceutical intermediate Substances 0.000 description 1
- 125000001792 phenanthrenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 description 1
- 125000005561 phenanthryl group Chemical group 0.000 description 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004346 phenylpentyl group Chemical group C1(=CC=CC=C1)CCCCC* 0.000 description 1
- 125000004344 phenylpropyl group Chemical group 0.000 description 1
- 238000007146 photocatalysis Methods 0.000 description 1
- 238000013032 photocatalytic reaction Methods 0.000 description 1
- 239000012994 photoredox catalyst Substances 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000001042 pteridinyl group Chemical group N1=C(N=CC2=NC=CN=C12)* 0.000 description 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000003410 quininyl group Chemical group 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 230000000707 stereoselective effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 125000000565 sulfonamide group Chemical group 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- PJYFEMRXRXRMSS-UHFFFAOYSA-N tert-butyl n-(thiophen-2-ylmethyl)carbamate Chemical compound CC(C)(C)OC(=O)NCC1=CC=CS1 PJYFEMRXRXRMSS-UHFFFAOYSA-N 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000005888 tetrahydroindolyl group Chemical group 0.000 description 1
- 125000003039 tetrahydroisoquinolinyl group Chemical group C1(NCCC2=CC=CC=C12)* 0.000 description 1
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 125000000147 tetrahydroquinolinyl group Chemical group N1(CCCC2=CC=CC=C12)* 0.000 description 1
- 125000004632 tetrahydrothiopyranyl group Chemical group S1C(CCCC1)* 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000005307 thiatriazolyl group Chemical group S1N=NN=C1* 0.000 description 1
- 125000001984 thiazolidinyl group Chemical group 0.000 description 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 150000003577 thiophenes Chemical class 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 125000004306 triazinyl group Chemical group 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 125000001834 xanthenyl group Chemical group C1=CC=CC=2OC3=CC=CC=C3C(C12)* 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B61/00—Other general methods
- C07B61/02—Generation of organic free radicals; Organic free radicals per se
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C315/00—Preparation of sulfones; Preparation of sulfoxides
- C07C315/04—Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
- C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C67/347—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by addition to unsaturated carbon-to-carbon bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/127—Preparation from compounds containing pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- C07D453/04—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The application relates to the technical field of synthetic chemistry, in particular to a photo-oxidation reduction catalytic method. The photo-redox catalytic method comprises the following steps: providing a linear tertiary alcohol compound and a free radical trapping agent; and carrying out catalytic reaction on the linear tertiary alcohol compound and the free radical capture reagent under the condition of a photocatalyst. The application provides a new method for alcohol extension alkyl free radical chemistry, under the condition of a photocatalyst, linear tertiary alcohol generates alkyl free radicals through single electron oxidation induced carbon-carbon bond fracture, and then the alkyl free radicals are captured by a free radical capture reagent to react to obtain various products; the photooxidation reduction catalysis method obviously reduces the production cost for preparing the captured product, and greatly expands the designability and application prospect of the product.
Description
The application is a divisional application with the application number 202110588659.3 and the application date 2021-05-28, and the application name of photo-redox catalytic method.
Technical Field
The application belongs to the technical field of synthetic chemistry, and particularly relates to a photo-oxidation reduction catalytic method.
Background
In recent years, with the understanding of photocatalytic mechanism and development of photo-redox catalysts, visible light-promoted photo-redox catalysis (photoredox catalysis) has been rapidly developed, and remarkable achievement has been achieved, and modern free radical chemistry has been thoroughly changed.
Through research, alkyl radicals play an indispensable role in the development of novel synthesis methods under photo/electrochemical catalysis. In general, alkyl radical precursors undergo single electron transfer with the aid of a photo-redox catalyst to generate transient alkyl radicals that can participate in various bond formation processes in a chemical and stereoselective manner, and a number of alkyl radical precursors have been developed that have a built-in redox group that reduces the energy gap between the substrate and the excited state of the photosensitizer. Despite the remarkable progress of the above-described studies, the use of common, environmentally friendly chemical raw materials to generate alkyl radicals in a precisely controlled manner has received little attention. The direct generation of alkyl radicals from simple, unactivated alcohols remains a primary challenge in photo-redox catalysis due to the high oxidation potential of alcohols.
Disclosure of Invention
The application aims to provide a photo-redox catalytic method, which aims to solve the technical problem of how to use linear tertiary alcohol to expand designable compounds at low cost.
In order to achieve the purposes of the application, the technical scheme adopted by the application is as follows:
A photo-redox catalytic method comprising the steps of:
providing a linear tertiary alcohol compound and a free radical trapping agent;
Carrying out catalytic reaction on a linear tertiary alcohol compound and a free radical capture reagent under the conditions of a photocatalyst and blue light;
The linear tertiary alcohol compound comprises
Wherein n=an integer of 0 to 4, R 1、R2 and R 3 are each independently selected from C 1-C20 alkyl, C 1-C20 heteroalkyl, C 3-C20 cycloalkyl, C 3-C20 heterocycloalkyl, C 2-C20 alkenyl, C 2-C20 heteroalkenyl, C 3-C20 cycloalkenyl, C 3-C20 heterocycloalkenyl, C 2-C20 alkynyl, C 2-C20 heteroalkynyl, C 3-C20 cycloalkynyl, C 3-C20 heterocycloalkynyl, c 1-C20 alkoxy, C 6-C14 aryl, substituted (C 6-C14) aryl, C 4-C14 heteroaryl, substituted (C 4-C14) heteroaryl, C 6-C14 aryloxy, C 4-C14 heteroaryloxy, C 6-C14 aryl (C 1-C20) alkyl, C 4-C14 heteroaryl (C 1-C20) alkyl, C 2-C20 alkenyl (C 1-C20) alkyl, C 2-C20 alkynyl (C 1-C20) alkyl, cyano (C 1-C20) alkyl, Any one of C 1-C20 alkyloxycarbonyl (C 1-C20) alkyl, C 3-C20 alkylsilyl, halogen, trifluoromethoxy, sulfonamide, and hydrogen atom; and R 2 and R 3 are not hydrogen atoms; The substituents in the substituted (C 6-C14) aryl and the substituted (C 4-C14) heteroaryl are each independently selected from the group consisting of halogen atoms, C 1-C5 alkyl groups, C 1-C5 alkoxy groups, At least one of a nitro group and an acyl group;
the free radical capture reagent is selected from heterocyclic compounds, and the heterocyclic compounds are selected from at least one of quinoline, quinoline derivatives, pyridine derivatives, thiazole derivatives, benzothiazole derivatives, pyrazine derivatives, pyrimidine derivatives, purine and purine derivatives;
The photocatalyst is selected from acridine salt type catalysts;
The photocatalytic reaction is also added with a Bronsted acid reagent, an oxidant and an acetonitrile solvent.
The photooxidation reduction catalysis method provided by the application is a new method for expanding alkyl free radical chemistry by alcohol, under the condition of a photocatalyst, linear tertiary alcohol generates alkyl free radicals by single-electron oxidation induced carbon-carbon bond fracture, and then the alkyl free radicals are captured by a free radical capture reagent to react to obtain various products; the photo-oxidation reduction catalysis method obviously reduces the production cost for preparing the captured product, greatly expands the designability and application prospect of the product, and can be widely applied to the fields of organic synthetic chemistry, biochemistry, asymmetric catalysis, pesticides and medicine research.
Detailed Description
In order to make the technical problems, technical schemes and beneficial effects to be solved more clear, the application is further described in detail below with reference to the embodiments. It should be understood that the specific embodiments described herein are for purposes of illustration only and are not intended to limit the scope of the application.
In the present application, the term "and/or" describes an association relationship of an association object, which means that three relationships may exist, for example, a and/or B may mean: a alone, a and B together, and B alone. Wherein A, B may be singular or plural. The character "/" generally indicates that the context-dependent object is an "or" relationship. "at least one" means one or more, and "plurality" means two or more. "at least one of" or the like means any combination of these items, including any combination of single item(s) or plural items(s). It should be understood that, in various embodiments of the present application, the sequence number of each process described above does not mean that the execution sequence of some or all of the steps may be executed in parallel or executed sequentially, and the execution sequence of each process should be determined by its functions and internal logic, and should not constitute any limitation on the implementation process of the embodiments of the present application.
The terminology used in the embodiments of the application is for the purpose of describing particular embodiments only and is not intended to be limiting of the application. As used in this application and the appended claims, the singular forms "a," "an," and "the" are intended to include the plural forms as well, unless the context clearly indicates otherwise. The weights of the relevant components mentioned in the description of the embodiments of the present application may refer not only to the specific contents of the components, but also to the proportional relationship between the weights of the components, so long as the contents of the relevant components in the description of the embodiments of the present application are scaled up or down within the scope of the disclosure of the embodiments of the present application. Specifically, the mass described in the specification of the embodiment of the application can be a mass unit which is known in the chemical industry field such as mu g, mg, g, kg.
The compounds and derivatives thereof referred to in the examples of the present application are named according to the IUPAC (International Union of pure and applied chemistry) or CAS (chemical abstract service Co., ltd., columbus, ohio) naming system. Thus, the compound groups specifically referred to in the examples of the present application are described and illustrated as follows:
With respect to "hydrocarbon groups", the minimum and maximum values of the carbon atom content in the hydrocarbon groups are indicated by a prefix, for example, the prefix (Ca-Cb) alkyl indicates any alkyl group containing from "a" to "b" carbon atoms. Thus, for example, (C 1-C6) alkyl refers to alkyl groups containing one to six carbon atoms.
"Alkoxy" refers to a straight or branched saturated aliphatic chain bonded to an oxygen atom and includes, but is not limited to, groups such as methoxy, ethoxy, propoxy, butoxy, isobutoxy, t-butoxy, and the like. (C a-Cb) alkoxy means any straight or branched, monovalent, saturated aliphatic chain having an alkyl group of "a" to "b" carbon atoms bonded to an oxygen atom.
"Alkyl" refers to a straight or branched saturated aliphatic chain including, but not limited to, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, hexyl, and the like.
"Heteroalkyl" refers to a straight or branched, saturated aliphatic chain containing at least one heteroatom attached, such as, but not limited to, methylaminoethyl, methyloxypropyl, or other similar groups.
"Alkenyl" refers to straight or branched chain hydrocarbons with one or more double bonds, including but not limited to, e.g., ethenyl, propenyl, and the like.
"Heteroalkenyl" refers to a straight or branched hydrocarbon containing at least one heteroatom linkage bearing one or more double bonds, including but not limited to, e.g., vinylaminoethyl or other similar groups.
"Alkynyl" refers to a straight or branched hydrocarbon bearing one or more triple bonds, including but not limited to, e.g., ethynyl, propynyl, and the like.
"Heteroalkynyl" refers to a straight or branched hydrocarbon containing at least one heteroatom linkage, bearing one or more triple bonds.
"Aryl" refers to a cyclic aromatic hydrocarbon, which may be a single or multiple ring or fused ring aromatic hydrocarbon, including, but not limited to, groups such as phenyl, naphthyl, anthryl, phenanthryl, and the like.
"Heteroaryl" means that one or more carbon atoms in a monocyclic or polycyclic or fused ring aromatic hydrocarbon have been replaced by heteroatoms such as nitrogen, oxygen or sulfur. If the heteroaryl group contains more than one heteroatom, these heteroatoms may be the same or may be different. Heteroaryl groups include, but are not limited to, benzofuranyl, benzothienyl, benzimidazolyl, benzoxazolyl, benzothiazolyl, benzopyranyl, furanyl, imidazolyl, indazolyl, indolizinyl, indolyl, isobenzofuranyl, isoindolyl, isoquinolyl, isothiazolyl, isoxazolyl, naphthyridinyl, oxadiazolyl, oxazinyl, oxazolyl, phthalazinyl, pteridinyl, purinyl, pyranyl, pyrazinyl, pyrazolyl, pyridazinyl, pyridin [3,4-b ] indolyl, pyridinyl, pyrimidinyl, pyrrolyl, quinolizinyl, quinolinyl, quinoxalinyl, thiadiazolyl, thiatriazolyl, thiazolyl, thienyl, triazinyl, triazolyl, xanthenyl, and the like.
"Cycloalkyl" refers to a saturated monocyclic or polycyclic alkyl group, possibly fused to an aromatic hydrocarbon group. Cycloalkyl groups include, but are not limited to, for example, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, indanyl, tetrahydronaphthyl, and the like.
"Heterocycloalkyl" means a saturated monocyclic or polycyclic alkyl group in which at least one carbon atom has been replaced by a heteroatom such as nitrogen, oxygen or sulfur, possibly fused to an aromatic hydrocarbon group. If the heterocycloalkyl group contains more than one heteroatom, these heteroatoms may be the same or different. Heterocyclylalkyl groups include, but are not limited to, for example, azabicycloheptyl, azetidinyl, indolinyl, morpholinyl, pyrazinyl, piperidinyl, pyrrolidinyl, tetrahydrofuranyl, tetrahydroquinolinyl, tetrahydroindazolyl, tetrahydroindolyl, tetrahydroisoquinolinyl, tetrahydropyranyl, tetrahydroquinoxalinyl, tetrahydrothiopyranyl, thiazolidinyl, thiomorpholinyl, thioxanthyl, thiooxalkyl, and the like.
"Cycloalkenyl" refers to an unsaturated monocyclic or polycyclic alkenyl group with one or more double bonds, possibly fused to an aromatic hydrocarbon group, including but not limited to cyclic vinyl, cyclopropenyl, or other similar groups.
"Heterocycloalkenyl" refers to an unsaturated monocyclic or polycyclic alkenyl group having one or more double bonds in which at least one carbon atom is replaced with a heteroatom such as nitrogen, oxygen or sulfur, possibly fused to an aromatic hydrocarbon group. If the heterocycloalkyl group contains more than one heteroatom, these heteroatoms may be the same or different.
"Cycloalkynyl" refers to an unsaturated, mono-or polycyclic alkynyl group bearing one or more triple bonds, possibly fused to an aromatic hydrocarbon group, including but not limited to cycloalkynyl, cyclopropynyl, or other like groups.
"Heterocycloalkynyl" refers to an unsaturated monocyclic or polycyclic alkynyl group having one or more triple bonds in which at least one carbon atom is replaced with a heteroatom such as nitrogen, oxygen or sulfur, possibly fused to an aromatic hydrocarbon group. If the heterocycloalkynyl contains more than one heteroatom, these heteroatoms may be the same or may be different.
The hetero atom may be an oxygen atom, a nitrogen atom, a sulfur atom, or the like.
"Tertiary alcohol" refers to a tertiary alcohol, i.e., an alcohol having three non-hydrogen substituent groups at the position of the hydroxyl group. "Linear tertiary alcohol" means that the carbon at the position of the hydroxyl group of the tertiary alcohol is linear or straight (linear), and "cyclic tertiary alcohol" corresponding to this means that the carbon at the position of the hydroxyl group of the tertiary alcohol is cyclic.
The embodiment of the application provides a photo-redox catalytic method, which comprises the following steps:
S01: providing a linear tertiary alcohol compound and a free radical trapping agent;
S02: the linear tertiary alcohol compound and the free radical capture reagent are subjected to catalytic reaction under the condition of a photocatalyst.
The photooxidation reduction catalysis method provided by the application is a new method for expanding alkyl free radical chemistry by alcohol, under the condition of a photocatalyst, linear tertiary alcohol generates alkyl free radicals by single-electron oxidation induced carbon-carbon bond fracture, and then the alkyl free radicals are captured by a free radical capture reagent to react to obtain various products; the photooxidation reduction catalysis method obviously reduces the production cost for preparing the captured product, greatly expands the designability and application prospect of the product, and the reactant raw materials provided by the embodiment of the application are very easy to obtain, and the reactant before reaction does not need to be subjected to additional modification and can be directly used for preparation and production, so that the operation steps are simplified, and the reaction route is shortened; the production cost is obviously reduced, and the method can be widely applied to the fields of organic synthetic chemistry, biochemistry, asymmetric catalysis, pesticides and medicine research.
In the above-mentioned step S01,
The linear tertiary alcohol compound comprises
Wherein n=an integer of 0 to 4 (e.g., n may be 0, 1,2, 3 or 4), R 1、R2 and R 3 are each independently selected from C 1-C20 alkyl, C 1-C20 heteroalkyl, C 3-C20 cycloalkyl, C 3-C20 heterocycloalkyl, C 2-C20 alkenyl, C 2-C20 heteroalkenyl, C 3-C20 cycloalkenyl, C 3-C20 heterocycloalkenyl, C 2-C20 alkynyl, C 2-C20 heteroalkynyl, C 3-C20 cycloalkynyl, C 3-C20 heterocycloalkynyl, C 1-C20 alkoxy, aryl, substituted aryl, heteroaryl, substituted heteroaryl, aryloxy, heteroaryloxy, aryl (C 1-C20) alkyl, heteroaryl (C 1-C20) alkyl, C 2-C20 alkenyl (C 1-C20) alkyl, C 2-C20 alkynyl (C 1-C20) alkyl, cyano (C 1-C20) alkyl, C 1-C20 alkyloxycarbonyl (C 1-C20) alkyl, Any one of C 3-C20 alkyl silicon group, halogen, trifluoromethoxy group, sulfonamide group and hydrogen atom; And R 2 and R 2 are not hydrogen atoms.
R 1、R2 and R 3 are identical or different and are selected from C 1-C20 alkyl, C 1-C20 heteroalkyl, C 3-C20 cycloalkyl, C 3-C20 heterocycloalkyl, C 2-C20 alkenyl, C 2-C20 heteroalkenyl, C 3-C20 cycloalkenyl, C 3-C20 heterocycloalkenyl, C 2-C20 alkynyl, C 2-C20 heteroalkynyl, C 3-C20 cycloalkynyl, C 3-C20 heterocycloalkynyl, C 1-C20 alkoxy, Aryl, substituted aryl, heteroaryl, substituted heteroaryl, aryloxy, heteroaryloxy, aryl (C 1-C20) alkyl, heteroaryl (C 1-C20) alkyl, C 2-C20 alkenyl (C 1-C20) alkyl, C 2-C20 alkynyl (C 1-C20) alkyl, cyano (C 1-C20) alkyl, C 1-C20 alkyloxycarbonyl (C 1-C20) alkyl, Any one of C 3-C20 alkyl silicon group, halogen (such as fluorine, chlorine, bromine and iodine), trifluoro methoxy, sulfonamide and hydrogen atom, which means that R 1、R2 and R 3 are respectively and independently selected from the above groups, and can be the same or different; And R 2 and R 2 are not hydrogen atoms.
When R 1、R2 or R 3 is selected from C 1-C20 alkyl, in one embodiment, the (C 1-C20) alkyl can be (C 1-C10) alkyl, (C 1-C5) alkyl, (C 1-C4) alkyl, (C 1-C3) alkyl, (C 1-C2) alkyl, and the like. In certain embodiments, (C 1-C20) alkyl may be methyl, ethyl, propyl, butyl, isobutyl, pentyl, isopentyl, and the like.
When R 1、R2 or R 3 is selected from (C 1-C20) heteroalkyl, in one embodiment, the (C 1-C20) heteroalkyl may be (C 1-C10) heteroalkyl, (C 2-C5) heteroalkyl, (C 3-C4) heteroalkyl, and the like. In certain embodiments, the heteroatom may be an atom, a nitrogen atom, a sulfur atom, or the like.
When R 1、R2 or R 3 is selected from (C 3-C20) cycloalkyl, in one embodiment, the (C 3-C20) cycloalkyl can be (C 3-C10) cycloalkyl, (C 3-C5) cycloalkyl, (C 3-C4) cycloalkyl, and the like. In certain embodiments, (C 3-C20) cycloalkyl may be cyclopropyl, cyclobutyl, cyclopentyl, and the like.
When R 1、R2 or R 3 is selected from (C 3-C20) heterocycloalkyl, in one embodiment, the (C 3-C20) heterocycloalkyl may be (C 3-C10) heterocycloalkyl, (C 3-C10) heterocycloalkyl, (C 3-C5) heterocycloalkyl, (C 3-C4) heterocycloalkyl, and the like. In certain embodiments, the heteroatom may be an oxygen atom, a nitrogen atom, a sulfur atom, or the like.
When R 1、R2 or R 3 is selected from (C 2-C20) alkenyl, in one embodiment, the (C 2-C20) alkenyl can be (C 3-C10) alkenyl, (C 3-C5) alkenyl, (C 3-C4) alkenyl, (C 2-C3) alkenyl, and the like. In certain embodiments, (C 2-C20) alkenyl may be ethenyl, propenyl, butenyl, pentenyl, and the like.
When R 1、R2 or R 3 is selected from (C 2-C20) heteroalkenyl, in one embodiment, the (C 2-C20) heteroalkenyl may be (C 2-C10) heteroalkenyl, (C 3-C10) heteroalkenyl, (C 3-C5) heteroalkenyl, and the like. In certain embodiments, the heteroatom may be halogen, nitrogen atom, sulfur atom, or the like.
When R 1、R2 or R 3 is selected from (C 3-C20) cycloalkenyl, in one embodiment, the (C 3-C20) cycloalkenyl may be (C 3-C10) cycloalkenyl, (C 3-C5) cycloalkenyl, (C 3-C4) cycloalkenyl, and the like. In certain embodiments, (C 3-C20) cycloalkenyl may be cyclopropenyl, cyclobutenyl, cyclopentenyl, and the like.
When R 1、R2 or R 3 is selected from (C 3-C20) heterocycloalkenyl, in one embodiment, the (C 3-C20) heterocycloalkenyl can be (C 3-C10) heterocycloalkenyl, (C 3-C5) heterocycloalkenyl, (C 3-C4) heterocycloalkenyl, and the like. In certain embodiments, the heteroatom may be halogen, nitrogen atom, sulfur atom, or the like.
When R 1、R2 or R 3 is selected from (C 2-C20) alkynyl, in one embodiment, the (C 2-C20) alkynyl may be (C 2-C10) alkynyl, (C 3-C10) alkynyl, (C 3-C5) alkynyl, (C 3-C4) alkynyl, (C 2-C3) alkynyl, and the like. In certain embodiments, (C 2-C20) alkynyl may be ethynyl, propynyl, butynyl, pentynyl, and the like.
When R 1、R2 or R 3 is selected from (C 2-C20) heteroalkynyl, (C 2-C20) heteroalkynyl, (C 3-C10) heteroalkynyl, (C 3-C5) heteroalkynyl, (C 3-C4) heteroalkynyl, and the like, in one embodiment, the (C 2-C20) heteroalkynyl may be (C 2-C10) heteroalkynyl, (C 3-C10) heteroalkynyl, and the like. In certain embodiments, the heteroatom may be halogen, nitrogen atom, sulfur atom, or the like.
When R 1、R2 or R 3 is selected from (C 3-C20) cycloalkynyl, in one embodiment, the (C 3-C20) cycloalkynyl can be (C 3-C10) cycloalkynyl, (C 3-C5) cycloalkynyl, (C 3-C4) cycloalkynyl, and the like. In certain embodiments, (C 2-C20) cycloalkynyl may be cyclopropynyl, cyclobutynyl, cyclopentynyl, and the like.
When R 1、R2 or R 3 is selected from (C 3-C20) heterocycloalkynyl, in one embodiment, the (C 3-C20) heterocycloalkynyl can be (C 3-C10) heterocycloalkynyl, (C 3-C5) heterocycloalkynyl, (C 3-C4) heterocycloalkynyl, and the like. In certain embodiments, the heteroatom may be halogen, nitrogen atom, sulfur atom, or the like.
When R 1、R2 or R 3 is selected from (C 1-C20) alkoxy, in one embodiment, the (C 1-C20) alkoxy may be (C 1-C10) alkoxy, (C 1-C8) alkoxy, (C 1-C6) alkoxy, (C 1-C4) alkoxy, (C 1-C3) alkoxy, (C 1-C2) alkoxy. In certain embodiments, the (C 1-C20) alkoxy group may be, but is not limited to, methyl oxy, ethyl oxy, propyl oxy, and the like.
When R 1、R2 or R 3 is selected from aryl, the aryl may be, but is not limited to, monocyclic aryl, polycyclic aryl, fused ring aryl. In one embodiment, the aryl is a monocyclic aryl. In certain embodiments, the aryl group may be a C 4-C14 aryl group, such as phenyl, naphthyl, fluorenyl, anthracenyl, phenanthrenyl, and the like.
When R 1、R2 or R 3 is selected from substituted aryl groups, the substituted aryl groups may be, but are not limited to, ortho, meta, para single or multiple substituted phenyl groups. Substituents include, but are not limited to, alkyl, substituted alkyl, aryl, substituted aryl, acyl, halogen, alkoxy, nitro. Wherein, when the substituent is an alkyl group, the alkyl group is for example but not limited to methyl, ethyl, propyl, butyl, isobutyl; when the substituent is a substituted alkyl group, such as, but not limited to, trifluoromethyl, trichloromethyl, pentafluoroethyl, pentachloroethyl; when the substituent is halogen, such as, but not limited to, fluorine, chlorine, bromine, iodine; when the substituent is an alkoxy group, the alkoxy group is for example, but not limited to, a methyloxy group, an ethyloxy group, a propyloxy group. In one embodiment, the substituted aryl may be a substituted (C 4-C14) aryl, such as may be cyano (C 1-C10) alkyl (C 4-C8) aryl, substituted (C 4-C8) aryl.
When R 1、R2 or R 3 is selected from heteroaryl, in one embodiment, the heteroaryl may be (C 4-C14) heteroaryl, such as thienyl, thiazolyl, pyrrolyl, pyrazinyl, pyridyl, benzothiophene, and the like.
When R 1、R2 or R 3 is selected from substituted heteroaryl, in one embodiment, the substituted heteroaryl may be a substituted (C 4-C14) heteroaryl, such as an alkoxy substituted furan, (C 3-C8) heteroaryl substituted furan, a fatty chain substituted thiophene, and the like.
When R 1、R2 or R 3 is selected from aryloxy, in one embodiment, the aryloxy may be a C 4-C14 aryloxy such as phenoxy, naphthoxy, anthracenoxy, phenanthryloxy, and the like.
When R 1、R2 or R 3 is selected from heteroaryloxy, in one embodiment, the heteroaryloxy may be C 4-C14 heteroaryloxy.
When R 1、R2 or R 3 is selected from aryl (C 1-C20) alkyl, in one embodiment, the aryl (C 1-C20) alkyl can be C 4-C14 aryl (C 1-C10) alkyl, such as phenyl (C 1-C10) alkyl, phenyl (C 1-C5) alkyl, phenyl (C 1-C4) alkyl, phenyl (C 1-C3) alkyl, phenyl (C 1-C2) alkyl, and the like. In certain embodiments, aryl (C 1-C20) alkyl may be phenylmethyl, phenylethyl, phenylpropyl, phenylbutyl, phenylisobutyl, phenylpentyl, phenylisopentyl, phenylneopentyl, and the like.
When R 1、R2 or R 3 is selected from heteroaryl (C 1-C20) alkyl, in one embodiment, the heteroaryl (C 1-C20) alkyl can be C 4-C14 heteroaryl (C 1-C10) alkyl, such as heteroaryl (C 1-C10) alkyl, heteroaryl (C 1-C5) alkyl, heteroaryl (C 1-C4) alkyl, heteroaryl (C 1-C3) alkyl, heteroaryl (C 1-C2) alkyl, and the like.
When R 1、R2 or R 3 is selected from (C 2-C20) alkenyl (C 1-C20) alkyl, in one embodiment, the (C 2-C20) alkenyl (C 1-C20) alkyl may be (C 2-C10) alkenyl (C 1-C10) alkyl, (C 2-C5) alkenyl (C 1-C3) alkyl, and the like.
When R 1、R2 or R 3 is selected from (C 2-C20) alkynyl (C 1-C20) alkyl, in one embodiment, the (C 2-C20) alkynyl (C 1-C20) alkyl may be (C 2-C10) alkynyl (C 1-C10) alkyl, (C 2-C5) alkynyl (C 1-C3) alkyl, and the like.
When R 1、R2 or R 3 is selected from cyano (C 1-C20) alkyl, in one embodiment, the cyano (C 1-C20) alkyl can be cyano (C 1-C10) alkyl, cyano (C 1-C5) alkyl, cyano (C 1-C4) alkyl, cyano (C 1-C3) alkyl, cyano (C 1-C2) alkyl, and the like. In certain embodiments, the cyano (C 1-C20) alkyl group can be cyanomethyl, cyanoethyl, cyanopropyl, cyanobutyl, cyanopentyl, and the like.
When R 1、R2 or R 3 is selected from C 3-C20 alkylsilyl, in one embodiment, the C 3-C20 alkylsilyl may be C 3-C18 alkylsilyl, C 3-C10 alkylsilyl, C 3-C5 alkylsilyl, and the like.
When R 1、R2 or R 3 is selected from C 1-C20 alkyloxycarbonyl (C 1-C20) alkyl, in one embodiment, the C 1-C20 alkyloxycarbonyl (C 1-C20) alkyl can be (C 1-C10) alkyloxycarbonyl (C 1-C10) alkyl, (C 1-C5) alkyloxycarbonyl (C 1-C5) alkyl, (C 1-C4) alkyloxycarbonyl (C 1-C4) alkyl, and the like.
The radical trapping agent may be at least one selected from the group consisting of electron-deficient alkenyl group-containing compounds, heterocyclic compounds, and thiotrifluoromethyl radical precursors, and for example, the present application is selected from the group consisting of heterocyclic compounds. The unactivated linear tertiary alcohols of the present application are oxidized by a photocatalyst, and the resulting alkoxy groups selectively undergo β -scission to deliver alkyl radicals that can be accepted by a variety of nucleophiles, thereby being captured by the radical capture reagents described above for addition or substitution to yield the product.
Specifically, the electron-deficient alkenyl-containing compound of the radical trapping agent is selected from at least one of benzyl malononitrile, 1-bis (phenylsulfonyl) ethylene, methyl 2-phenylacrylate and 2-vinylpyridine; the above electron-deficient alkenyl group-containing compound is catalytically reacted with a linear tertiary alcohol compound to obtain an addition product of a primary alkyl radical, a secondary alkyl radical or a tertiary alkyl radical with the above-mentioned electron-deficient alkenyl group-containing compound such as benzyl malononitrile, 1-bis (phenylsulfonyl) ethylene, methyl 2-phenylacrylate, 2-vinylpyridine and the like.
Or the heterocyclic compound of the radical trapping agent is a heterocyclic compound containing a nitrogen atom, such as at least one selected from the group consisting of quinoline, a quinoline derivative, pyridine, a pyridine derivative, thiazole, a thiazole derivative, benzothiazole, a benzothiazole derivative, pyrazine, a pyrazine derivative, pyrimidine, a pyrimidine derivative, purine and a purine derivative; the heterocyclic compound and linear tertiary alcohol compound are subjected to catalytic reaction to obtain a primary alkyl free radical, a secondary alkyl free radical or a tertiary alkyl free radical which reacts with the heterocyclic compound to generate a monosubstituted alkyl substituted product. Further, the quinoline derivatives may be quinoline substituted with an alkyl group or other groups, such as 2-methylquinoline, quinine, etc.; the pyridine derivative may be an alkyl group or other group-substituted pyridine such as 2, 6-lutidine and the like; the thiazole derivative can be thiazole substituted by alkyl or other groups, such as 5-methylthiazole-4-carboxylic acid ethyl ester and the like; the pyrazine derivatives can be alkyl or other groups substituted pyrazines, such as 2,3, 5-trimethylpyrazine and the like; the pyrimidine derivative may be an alkyl or other group-substituted pyrimidine such as 4, 6-dimethylpyrimidine, etc.; the above purine derivatives may be alkyl or other group substituted purines such as 2, 6-dichloro-9-methyl-9H-purine and the like.
Or the sulfur trifluoromethyl radical precursor of the radical trapping reagent is selected from N- (trifluoromethylthio) phthalimide, so that the sulfur trifluoromethyl radical precursor and linear tertiary alcohol compound are subjected to catalytic reaction to obtain the corresponding sulfur trifluoromethyl substituted alkyl product.
The linear tertiary alcohol compound acts as a nucleophile and is capable of attacking at least one of the electron deficient alkenyl containing compound, the heterocyclic compound and the thiotrifluoromethyl radical precursor, such that the two reactants react. Therefore, the atomic utilization rate of the reactant is effectively improved, the limitation of the substrate is widened, the target product precursor with high enantioselectivity and extremely wide range is efficiently and greenly prepared, and the product with potential application value is obtained through simple reduction reaction.
In one embodiment, the photocatalyst is an acridine salt catalyst as shown below;
Wherein X is tetrafluoroboric acid anion, hexafluorophosphoric acid anion or perchloric acid anion; R 4、R5 and R 6 are each independently selected from the group consisting of C 1-C20 alkyl, C 1-C20 heteroalkyl, C 3-C20 cycloalkyl, C 3-C20 heterocycloalkyl, C 2-C20 alkenyl, C 2-C20 heteroalkenyl, C 3-C20 cycloalkenyl, C 3-C20 heterocycloalkenyl, C 2-C20 alkynyl, C 2-C20 heteroalkynyl, C 3-C20 cycloalkynyl, C 3-C20 heterocycloalkynyl, C 1-C20 alkoxy, Aryl, substituted aryl, heteroaryl, substituted heteroaryl, aryloxy, heteroaryloxy, aryl (C 1-C20) alkyl, heteroaryl (C 1-C20) alkyl, (C 2-C20) alkenyl (C 1-C20) alkyl, Any one of (C 2-C20) alkynyl (C 1-C20) alkyl and cyano (C 1-C20) alkyl. the catalyst has better photo-oxidation reduction catalytic effect. In a preferred embodiment of the application, the photocatalyst is selected from the group consisting of Mes-Acr-PhBF 4.
Further, at least one of a bronsted acid reagent and an oxidizing agent is added to the above-mentioned catalytic reaction. Specifically, the two are added, and the photocatalyst, the oxidant and the Bronsted acid reagent act synergistically, so that the catalytic system has low toxicity, the atom utilization rate and the reaction efficiency are improved, and the byproducts are few; meanwhile, the reaction process is safe and controllable, and the operation in the preparation and production processes is simplified. The photocatalyst can provide better single-electron oxidation, so that the carbon-carbon bond breaking efficiency is improved in the catalytic reaction process; oxidizing agents and bronsted acid reagents are used for the addition reaction of free radicals with heterocycles. Specifically, the bronsted acid reagent is at least one selected from acetic acid, fluoroacetic acid, sulfuric acid, hydrochloric acid, perchloric acid, phosphoric acid and nitric acid; the oxidant is at least one selected from the group consisting of a hypervalent iodine compound, a peroxy compound, a quinone compound, a persulfate, potassium permanganate, oxygen and N-fluorobenzenesulfonimide.
Under the condition that the contents of the three are in a certain range and in proportion, the reaction has higher efficient catalytic efficiency, and the target product with higher yield is obtained. Specifically, the molar ratio of the photocatalyst to the oxidant to the Bronsted acid reagent is (0.1-20): 0.2-40. Under the proportion, the reaction has high catalytic efficiency, and is favorable for improving the yield of reaction products. Preferably, the molar ratio of the photocatalyst, the oxidizing agent and the Bronsted acid reagent is (0.2-20) 2.5 (1-10), in which case the highest yield of the target product is advantageously obtained.
In one embodiment, the catalytic reaction is performed by dissolving a linear tertiary alcohol compound and a free radical trapping reagent in an acetonitrile solution; further, the catalytic reaction is carried out under blue light conditions. For example, linear tertiary alcohol and a free radical capture reagent are added into acetonitrile solution containing acridine salt photocatalyst, and the mixture is reacted under blue light irradiation to obtain a product after alkyl free radical and the capture reagent are added, wherein the additive can comprise a Bronsted acid reagent and an oxidant.
The linear tertiary alcohol compound is oxidized through single electron transfer, so that carbon-carbon bond breakage is induced, and then the linear tertiary alcohol compound reacts with a free radical capture reagent; has the following advantages: the substrate range is wider by breaking the carbon-carbon bond of the linear tertiary alcohol, and the generated alkyl free radical can be captured by various free radical capture reagents. It is worth noting that quinine widely applied in asymmetry and medicines can be well modified, the reaction process is safe and controllable, and the operation in the preparation and production processes is simplified. In addition, the application obviously reduces the production cost for preparing the captured product, and greatly expands the designability and application prospect of the compound. The addition product obtained by the method has high functionality, is more diversified in the synthesis of the drug intermediate, the application of the functional material and the metal ligand, can be widely used for the synthesis of the drug intermediate, the preparation of the chiral ligand and the functional material, can effectively reduce the economic cost of the preparation of the drug intermediate and the functional material, and provides the environmental friendliness. The cleavage method and the capture product provided by the application have high functionality, and can be widely applied to the fields of organic synthetic chemistry, biochemistry, asymmetric catalysis, pesticides and medicine research, such as the fields of synthesis of pharmaceutical intermediates, particularly compounds containing hetero quaternary carbon center structures, and preparation of functional materials.
The application carries out photooxidation reduction catalytic reaction by using different kinds of linear tertiary alcohol compounds and different kinds of free radical capture reagents, thereby obtaining different kinds of products. Specifically, the embodiment of the application provides the photo-redox catalytic method, which utilizes different raw materials to obtain 21 products as follows.
The compound obtained by the photocatalysis method can be used for synthesizing a drug intermediate, preparing a functional material and a metal ligand, so that the preparation method has good application prospect.
The following description is made with reference to specific embodiments.
Example 1
A preparation method of 2- (1, 2-diphenyl ethyl) malononitrile compound (structural formula is shown as the following formula 1) comprises:
The photocatalyst Mes-Acr-PhBF 4 (0.01 mmol,4.6 mg) and the capture reagent benzyl malononitrile (0.4 mmol,61.7 mg) were weighed into oven-dried 8mL vials containing magnetic star bars. Anhydrous acetonitrile (1 mL) was added followed by linear tertiary alcohol (2-methyl-1-phenyl-2-propanol) (0.2 mmol). The reaction vessel was degassed, backfilled with argon, and then placed in a SynLED x4 photoreactor (SynLED discoverTM nm, designed and manufactured by Shenzhen SynLED tech. The progress of the reaction was monitored by TLC. After completion, the reaction mixture was concentrated and purified by flash column chromatography on silica gel to give the desired product in 85% yield.
The results of the correlation characterization analysis were 1H NMR(500MHz,Chloroform-d)δ7.47–7.38(m,5H),7.35(dd,J=8.1,6.4Hz,2H),7.32–7.28(m,1H),7.24–7.17(m,2H),3.86(d,J=5.1Hz,1H),3.48(ddd,J=8.6,7.2,5.1Hz,1H),3.35–3.22(m,2H).13C NMR(126MHz,Chloroform-d)δ136.66,136.46,129.23,129.18,129.10,128.94,128.05,127.61,112.07,111.46,48.40,38.57,28.56.HRMS(ESI-TOF)calculated for C17H14N2(M+Na+):269.1049,found:269.1049.. This result further demonstrates that the molecular structure of the product is as described above for molecular structure 1.
Example 2
A preparation method of 2- (1, 3-diphenylpropyl) malononitrile compound (structural formula is shown as the following formula 2):
the linear tertiary alcohol is 3-methyl-1-phenyl-3-amyl alcohol, and the capturing reagent is benzyl allyl dinitrile; otherwise, the same procedure as in example 1 was carried out, with a yield of 81%.
The result of the correlation characterization analysis is 1H NMR(500MHz,Chloroform-d)δ7.51–7.40(m,3H),7.38–7.28(m,4H),7.26–7.22(m,1H),7.14–7.07(m,2H),3.86(d,J=6.2Hz,1H),3.20(dt,J=10.2,5.7Hz,1H),2.66(ddd,J=13.6,8.3,5.2Hz,1H),2.48(dt,J=13.8,8.2Hz,1H),2.43–2.29(m,2H).13C NMR(126MHz,Chloroform-d)δ139.90,136.24,129.48,129.12,128.73,128.38,128.05,126.57,111.81,111.77,45.64,33.53,32.77,30.37.HRMS(ESI-TOF)calculated for C18H16N2(M+Na+):283.1206,found:283.1206.. This result further demonstrates that the molecular structure of the product is as described above for molecular structure 2.
Example 3
A process for producing a 2- (2- (4-isobutylphenyl) -1-phenylpropyl) malononitrile compound (structural formula 3:
The linear tertiary alcohol is 3- (4-isobutylphenyl) -2-methylbutan-2-ol, and the capture reagent is benzyl allyl dinitrile; otherwise, the same procedure as in example 1 was carried out, with a yield of 84% and a dr of 1:1.
Correlation characterization analysis, the result is isomer 1:1H NMR(500MHz,Chloroform-d)δ7.31–7.22(m,3H),7.01–6.90(m,4H),6.84(d,J=7.9Hz,2H),4.07(d,J=8.1Hz,1H),3.49(p,J=7.0Hz,1H),3.42(t,J=7.8Hz,1H),2.40(dd,J=7.2,1.8Hz,2H),1.80(dp,J=13.5,6.8Hz,1H),1.43(d,J=6.9Hz,3H),0.86(dd,J=6.6,1.5Hz,6H).13C NMR(126MHz,Chloroform-d)δ140.84,137.54,134.88,129.12,128.85,128.57,128.46,127.87,112.58,112.03,52.76,44.95,41.25,30.15,27.48,22.35,22.28,19.93.
Isomer 2:1H NMR(400MHz,Chloroform-d)δ7.58–7.42(m,5H),7.30(d,J=7.9Hz,2H),7.23(d,J=8.1Hz,2H),3.65(d,J=4.1Hz,1H),3.40(dq,J=11.5,6.8Hz,1H),3.20(dd,J=11.7,4.1Hz,1H),2.53(d,J=7.2Hz,2H),1.92(dp,J=13.5,6.7Hz,1H),1.16(d,J=6.8Hz,3H),0.96(d,J=6.6Hz,6H).13C NMR(101MHz,Chloroform-d)δ141.68,139.53,135.66,130.33,129.26,129.07,128.57,126.78,112.27,111.52,53.74,45.02,41.65,30.19,28.73,22.43,22.41,20.59.HRMS(ESI-TOF)calculated for C22H24N2(M-H+):315.1867,found:315.1868. this result further demonstrates the product molecular structure as described above for molecular structure 3.
Example 4
A process for producing a 2- (1, 2-diphenylbutyl) malononitrile compound (structural formula 4 shown below):
The linear tertiary alcohol is 2-methyl-3-phenylpentane-2-alcohol, and the capture reagent is benzyl allyl dinitrile; otherwise, the same procedure as in example 1 was carried out, with a yield of 93% and a dr of 1:1.
Correlation characterization analysis, the result is isomer 1:1H NMR(400MHz,Chloroform-d)δ7.34–7.26(m,3H),7.23(dd,J=5.2,1.9Hz,3H),7.00–6.84(m,4H),4.06(d,J=8.7Hz,1H),3.57(dd,J=8.7,7.1Hz,1H),3.26(ddd,J=10.5,7.1,4.7Hz,1H),1.89(dtd,J=14.5,7.3,4.7Hz,1H),1.78–1.64(m,1H),0.86(t,J=7.3Hz,3H).13C NMR(101MHz,Chloroform-d)δ138.03,134.70,129.05,128.85,128.60,128.46,128.37,127.41,112.60,111.96,51.41,49.07,27.39,26.51,11.97.
Isomer 2:1H NMR(400MHz,Chloroform-d)δ7.59–7.42(m,7H),7.42–7.33(m,3H),3.61(d,J=4.1Hz,1H),3.30(dd,J=11.8,4.1Hz,1H),3.15(td,J=11.4,3.4Hz,1H),1.65–1.38(m,2H),0.65(t,J=7.3Hz,3H).13C NMR(101MHz,Chloroform-d)δ140.23,135.80,129.64,129.33,129.11,128.52,128.11,127.91,112.17,111.46,52.67,49.60,28.81,27.03,12.02.HRMS(ESI-TOF)calculated for C19H18N2(M-H+):273.1397,found:273.1399. this result further demonstrates the product molecular structure as described above for molecular structure 4.
Example 5
A preparation method of 2- (2-methoxy-1-phenethyl) malononitrile compound (structural formula is shown as the following formula 5):
the photocatalyst Mes-Acr-PhBF 4 (0.01 mmol,4.6 mg) and the capture reagent benzyl malononitrile (0.2 mmol,30.8 mg) were weighed into oven-dried 8mL vials containing magnetic star bars. Anhydrous acetonitrile (1 mL) was added followed by linear tertiary alcohol (1-methoxy-2-phenylpropan-2-ol) (0.24 mmol). The reaction vessel was degassed, backfilled with argon, and then placed in a SynLED x4 photoreactor (SynLED discoverTM 450 nm). The progress of the reaction was monitored by TLC. After completion, the reaction mixture was concentrated and purified by flash column chromatography on silica gel to give the desired product in 92% yield.
The results of the correlation characterization analysis were 1H NMR(400MHz,Chloroform-d)δ7.51–7.33(m,5H),4.44(d,J=6.0Hz,1H),3.91–3.76(m,2H),3.48(m,4H).13C NMR(101MHz,Chloroform-d)δ134.46,129.26,128.16,112.12,111.63,71.58,59.34,46.43,26.30.HRMS(ESI-TOF)calculated for C12H12N2O(M-H+):199.0877,found:199.0874.. This result further demonstrates the product molecular structure as described above for molecular structure 5.
Example 6
A process for producing a 2- (phenyl (tetrahydro-2H-pyran-4-yl) methyl) malononitrile compound (structural formula 6:
The linear tertiary alcohol is 1-phenyl-1- (tetrahydro-2H-pyran-4-yl) ethan-1-ol, and the capture reagent is benzyl allyl dinitrile; otherwise, the same procedure as in example 5 was carried out, with a yield of 94%.
The results of the correlation characterization analysis were 1H NMR(500MHz,Chloroform-d)δ7.47–7.37(m,3H),7.37–7.32(m,2H),4.17(d,J=5.0Hz,1H),4.13–4.05(m,1H),3.95–3.85(m,1H),3.49(td,J=11.9,2.3Hz,1H),3.34(td,J=11.8,2.3Hz,1H),2.91(dd,J=10.2,5.0Hz,1H),2.28(dddt,J=11.6,10.2,7.6,3.8Hz,1H),1.82(ddd,J=12.6,4.0,2.1Hz,1H),1.49(qd,J=12.1,4.6Hz,1H),1.32(ddq,J=13.6,4.5,2.3Hz,1H),1.22(dtd,J=13.4,11.7,4.5Hz,1H).13C NMR(126MHz,Chloroform-d)δ135.77,129.38,129.13,128.25,111.81,111.67,67.56,67.14,52.01,37.03,31.10,30.70,26.85.HRMS(ESI-TOF)calculated for C15H16N2O(M-H+):239.1190,found:239.1189.. This result further demonstrates that the molecular structure of the product is as described above for molecular structure 6.
Example 7
A preparation method of 2- (1-phenyldodecyl) malononitrile compound (structural formula is shown as formula 7 below) comprises:
The linear tertiary alcohol is 2-phenyl-tridecyl-2-alcohol, and the capturing reagent is benzyl allyl dinitrile; otherwise, the same procedure as in example 5 was carried out, with a yield of 77%.
The results of the correlation characterization analysis were 1H NMR(400MHz,Chloroform-d)δ7.48–7.36(m,3H),7.36–7.30(m,2H),3.90(d,J=6.2Hz,1H),3.22(dt,J=8.9,6.5Hz,1H),2.02(td,J=8.3,5.9Hz,2H),1.42–1.17(m,18H),0.91(t,J=6.8Hz,3H).13C NMR(101MHz,Chloroform-d)δ136.84,129.27,128.85,127.82,111.93,46.61,32.11,31.89,30.27,29.57,29.54,29.45,29.31,29.25,29.13,26.96,22.68,14.12.HRMS(ESI-TOF)calculated for C21H30N2(M-H+):309.2336,found:309.2338.. This result further demonstrates the product molecular structure as described above for molecular structure 7.
Example 8
A method for producing a 2- ((4, 4-difluorocyclohexyl) (phenyl) methyl) malononitrile compound (structural formula 8 shown below):
The linear tertiary alcohol is 1- (4, 4-difluorocyclohexyl) -1-phenylethan-1-ol, and the capture reagent is benzyl allyl dinitrile; otherwise, the same procedure as in example 5 was carried out, with a yield of 76%.
The results of the correlation characterization analysis were 1H NMR(400MHz,Chloroform-d)δ7.51–7.39(m,3H),7.39–7.31(m,2H),4.19(d,J=5.2Hz,1H),2.98(dd,J=9.9,5.2Hz,1H),2.25(ttt,J=10.7,7.3,3.7Hz,1H),2.19–2.10(m,1H),2.04(ddt,J=13.9,7.2,3.5Hz,2H),1.89(dtt,J=34.9,13.7,4.0Hz,1H),1.80–1.60(m,1H),1.60–1.43(m,2H),1.33–1.19(m,1H).13C NMR(101MHz,Chloroform-d)δ136.16,129.46,129.19,127.96,111.65,51.21,37.67,33.02(t,J=24.0Hz),27.52,27.23(d,J=9.9Hz),26.82(d,J=9.7Hz).19F NMR(376MHz,Chloroform-d)δ-93.10(d,J=237.2Hz),-103.04(d,J=237.6Hz).HRMS(ESI-TOF)calculated for C16H16F2N2(M-H+):273.1209,found:273.1210.. This result further demonstrates the product molecular structure as described above for molecular structure 8.
Example 9
A method for preparing a 2- ((((3 r,5r,7 r) -adamantan-1-yl) (phenyl) methyl) malononitrile compound (structural formula is shown as the following formula 9):
the linear tertiary alcohol is 1- ((3 r,5r,7 r) -adamantan-1-yl) -1-phenylethan-1-ol, and the capture reagent is benzyl allyl dinitrile; otherwise, the same procedure as in example 5 was carried out, with a yield of 85%.
The results of the correlation characterization analysis were 1H NMR(500MHz,Chloroform-d)δ7.39(m,J=7.5Hz,5H),4.26(d,J=5.4Hz,1H),2.82(d,J=5.3Hz,1H),2.04(q,J=3.2Hz,3H),1.77–1.65(m,9H),1.61(m,3H).13C NMR(126MHz,Chloroform-d)δ135.34,129.70,128.63,128.57,113.48,113.33,58.09,40.44,36.58,36.39,28.43,23.79.HRMS(ESI-TOF)calculated for C20H22N2(M-H+):289.1710,found:289.1709.. This result further demonstrates the product molecular structure as described above for molecular structure 9.
Example 10
A process for producing a 2- (2- (allyloxy) -1-phenethyl) malononitrile compound (structural formula 10:
The linear tertiary alcohol was 1- (allyloxy) -2-phenylpropan-2-ol and the trapping agent was benzyl malononitrile in 68% yield in the same manner as in example 5.
The results of the correlation characterization analysis were 1H NMR(400MHz,Chloroform-d)δ7.43(tdd,J=7.2,5.6,2.1Hz,5H),5.95(ddt,J=17.3,10.4,5.7Hz,1H),5.43–5.20(m,2H),4.48(d,J=5.8Hz,1H),4.12(dt,J=5.7,1.4Hz,2H),3.95–3.77(m,2H),3.51(ddd,J=8.7,5.8,4.7Hz,1H).13C NMR(101MHz,Chloroform-d)δ134.46,133.59,129.26,128.18,118.25,112.14,111.64,72.55,69.02,46.51,26.39.HRMS(ESI-TOF)calculated for C14H14N2O(M-H+):225.1033,found:225.1028.. This result further demonstrates the product molecular structure as described above for molecular structure 10.
Example 11
A preparation method of a 4-isopropyl-2-methylquinoline compound (a structural formula is shown as the following formula 11):
The photocatalyst Mes-Acr-PhBF 4 (0.01 mmol,4.6 mg), ammonium persulfate (0.5 mmol) and the capture reagent heterocycle 2-methylquinoline (0.2 mmol) were weighed into oven dried 8mL vials containing magnetic star bars. H 2 O (0.1 mL) and MeCN (0.9 mL) were added followed by the linear tertiary alcohol 3-methyl-2-phenylbutan-2-ol (0.4 mmol) and then trifluoroacetic acid (0.4 mmol). The reaction vessel was degassed and backfilled with argon and then placed in a SynLED x4 photoreactor (SynLED discoverTM 450 nm). The progress of the reaction was monitored by TLC. After completion, the reaction mixture was quenched with 1N NaOH (10 mL). The combined organic layers were washed with brine, dried (Na 2SO4) and concentrated in vacuo. The crude product was purified by flash column over silica gel. Compound 11 yield 78%.
The results of the correlation characterization analysis were 1H NMR(400MHz,Chloroform-d)δ8.15–7.96(m,2H),7.68(ddd,J=8.5,6.9,1.4Hz,1H),7.52(ddd,J=8.2,6.9,1.4Hz,1H),7.21(s,1H),3.73(p,J=6.9Hz,1H),2.76(s,3H),1.42(d,J=6.9Hz,6H).13C NMR(101MHz,Chloroform-d)δ158.83,154.30,148.07,129.50,128.82,125.34,125.15,122.90,117.75,28.22,25.55,22.93.HRMS(ESI-TOF)calculated for C13H15N(M+H+):186.1277,found:186.1277.. This result further demonstrates that the molecular structure of the product is as described above for molecular structure 11.
Example 12
A preparation method of a 2-benzyl-3, 5, 6-trimethyl pyrazine compound (structural formula is shown in the following formula 12):
The linear tertiary alcohol was 2-methyl-1-phenyl-2-propanol, the trapping agent was 2,3, 5-trimethylpyrazine and the yield was 67% in the same manner as in example 11.
The results of the correlation characterization analysis were 1H NMR(400MHz,Chloroform-d)δ7.35–7.25(m,2H),7.24–7.13(m,3H),4.16(s,2H),2.54(s,3H),2.51(s,3H),2.44(s,3H).13C NMR(101MHz,Chloroform-d)δ150.14,148.96,148.58,148.55,138.48,128.57,128.44,126.29,41.19,21.54,21.50,21.27.HRMS(ESI-TOF)calculated for C14H16N2(M+H+):213.1386,found:213.1386.. This result further demonstrates that the molecular structure of the product is as described above for molecular structure 12.
Example 13
A process for producing a 2-isopropylbenzo [ d ] thiazole compound (structural formula 13:
the linear tertiary alcohol is 3-methyl-2-phenyl butane-2-alcohol, and the capture reagent is benzothiazole; otherwise, the same procedure as in example 11 was carried out, with a yield of 83%.
The results of the correlation characterization analysis were 1H NMR(400MHz,Chloroform-d)δ8.01(d,J=8.2Hz,1H),7.88(d,J=8.0Hz,1H),7.48(t,J=7.7Hz,1H),7.37(t,J=7.6Hz,1H),3.46(p,J=6.9Hz,1H),1.52(d,J=6.9Hz,6H).13C NMR(101MHz,Chloroform-d)δ178.64,153.11,134.68,125.84,124.58,122.57,121.55,34.10,22.91.HRMS(ESI-TOF)calculated for C10H11NS(M+H+):178.0685,found:178.0685.. This result further demonstrates that the molecular structure of the product is as described above for molecular structure 13.
Example 14
A method for preparing a 4-cyclohexyl-2, 6-lutidine compound (the structural formula is shown as the following formula 14):
The linear tertiary alcohol is 1-cyclohexyl-1-phenyl ethane-1-alcohol, and the capture reagent is 2, 6-dimethylpyridine; otherwise, the same procedure as in example 11 was carried out, with a yield of 51%.
The results of the correlation characterization analysis were 1H NMR(400MHz,Chloroform-d)δ6.82(s,2H),2.52(s,6H),2.44(dq,J=8.8,5.8,4.2Hz,1H),1.95–1.81(m,4H),1.81–1.73(m,1H),1.49–1.33(m,4H),1.33–1.19(m,1H).13C NMR(101MHz,Chloroform-d)δ157.43,157.21,118.91,43.85,33.56,26.60,26.01,24.42.HRMS(ESI-TOF)calculated for C13H19N(M+H+):190.1590,found:190.1589.. This result further demonstrates that the product molecular structure is as described above for molecular structure 14.
Example 15
A method for preparing a 2-cyclopentyl-4, 6-dimethylpyrimidine compound (structural formula shown as formula 15 below):
The linear tertiary alcohol is 1-cyclopentyl-1-phenylethan-1-ol, and the capture reagent is 4, 6-dimethylpyrimidine; otherwise, the same procedure as in example 11 was carried out, with a yield of 56%.
The results of the correlation characterization analysis were 1H NMR(500MHz,Chloroform-d)δ6.83(s,1H),3.26(p,J=8.4Hz,1H),2.45(s,6H),2.14–2.00(m,2H),1.98–1.80(m,4H),1.76–1.62(m,2H).13C NMR(126MHz,Chloroform-d)δ173.70,166.29,117.25,48.98,33.07,25.95,24.05.HRMS(ESI-TOF)calculated for C11H16N2(M+H+):177.1386,found:177.1386.. This result further demonstrates that the product molecular structure is as described above for molecular structure 15.
Example 16
A method for preparing a 2-isopropyl-5-methylthiazole-4-carboxylic acid ethyl ester compound (the structural formula is shown as the following formula 16):
The linear tertiary alcohol is 3-methyl-2-phenyl butane-2-alcohol, and the capture reagent is 5-methylthiazole-4-carboxylic acid ethyl ester; otherwise, the same procedure as in example 11 was carried out, with a yield of 61%.
The results of the correlation characterization analysis were 1H NMR(400MHz,Chloroform-d)δ4.42(q,J=7.1Hz,2H),3.36(p,J=6.9Hz,1H),2.74(s,3H),1.42(t,J=7.1Hz,3H),1.38(d,J=6.9Hz,6H).13C NMR(101MHz,Chloroform-d)δ174.06,162.68,143.60,140.41,61.01,33.45,23.34,14.45,13.27.HRMS(ESI-TOF)calculated for C10H15NO2S(M+H+):214.0896,found:214.0896.. This result further demonstrates that the product molecular structure is as described above for molecular structure 16.
Example 17
A method for preparing a 2, 6-dichloro-8-isopropyl-9-methyl-9H-purine compound (structural formula shown in the following formula 17):
The linear tertiary alcohol was 3-methyl-2-phenylbutane-2-ol, the trapping agent was 2, 6-dichloro-9-methyl-9H-purine, and the yield was 76% in the same manner as in example 11.
The results of the correlation characterization analysis were 1H NMR(500MHz,Chloroform-d)δ3.83(s,3H),3.25(p,J=6.9Hz,1H),1.47(d,J=6.9Hz,6H).13C NMR(126MHz,Chloroform-d)δ163.96,154.84,151.76,149.61,130.10,29.29,27.37,20.61.HRMS(ESI-TOF)calculated for C9H10Cl2N4(M+H+):245.0355,found:245.0356.. This result further demonstrates that the molecular structure of the product is as described above for molecular structure 17.
Example 18
A preparation method of 4, 4-dimethyl-2-phenyl methyl valerate compound (structural formula is shown as the following formula 18) comprises the following steps:
The photocatalyst Mes-Acr-PhBF 4 (0.01 mmol,4.6 mg) and the capture reagent methyl 2-phenylacrylate (0.4 mmol) were weighed into oven dried 8mL vials containing magnetic star bars. Anhydrous acetonitrile (1 mL) was added followed by linear tertiary alcohol 3, 3-dimethyl-2-phenylbutan-2-ol (0.2 mmol). The reaction vessel was degassed, backfilled with argon, and then placed in a SynLED x4 photoreactor (SynLED discoverTM 450 nm). The progress of the reaction was monitored by TLC. After completion, the reaction mixture was concentrated and purified by flash column chromatography on silica gel to give the target product in 73% yield.
The results of the correlation characterization analysis were 1H NMR(400MHz,Chloroform-d)δ7.40–7.29(m,4H),7.29–7.24(m,1H),3.69(dd,J=9.2,3.8Hz,1H),3.67(s,3H),2.34(dd,J=14.0,9.3Hz,1H),1.61(dd,J=14.0,3.8Hz,1H),0.93(s,9H).13C NMR(101MHz,Chloroform-d)δ175.25,140.91,128.62,127.78,127.02,52.04,48.07,47.41,31.00,29.38.HRMS(ESI-TOF)calculated for C14H20O2(M+H+):221.1536,found:221.1536.. This result further demonstrates that the product molecular structure is as described above for molecular structure 18.
Example 19
A method for preparing a (3, 3-dimethylbutane-1, 1-methylsulfonyl) benzene compound (structural formula is shown as the following formula 19):
The photocatalyst Mes-Acr-PhBF 4 (0.01 mmol,4.6 mg) and the capture reagent 1, 1-bis (benzenesulfonyl) ethylene (0.4 mmol) were weighed into oven-dried 8mL vials containing magnetic star bars. Anhydrous acetonitrile (1 mL) was added followed by linear tertiary alcohol 3, 3-dimethyl-2-phenylbutan-2-ol (0.2 mmol). The reaction vessel was degassed, backfilled with argon, and then placed in a SynLED x4 photoreactor (SynLED discoverTM 450 nm). The progress of the reaction was monitored by TLC. After completion, the reaction mixture was concentrated and purified by flash column chromatography on silica gel to give the desired product in 78% yield.
The results of the correlation characterization analysis were 1H NMR(400MHz,Chloroform-d)δ8.07–7.86(m,4H),7.76–7.65(m,2H),7.59(dd,J=8.4,7.2Hz,4H),4.44(t,J=4.0Hz,1H),2.22(d,J=4.1Hz,2H),0.91(s,9H).13C NMR(101MHz,Chloroform-d)δ138.19,134.50,129.91,129.06,81.73,36.61,31.21,29.22.HRMS(ESI-TOF)calculated for C18H22O4S2(M-H+):365.0887,found:365.0886.. This result further demonstrates the product molecular structure as described above for molecular structure 19.
Example 20
A method for preparing a 2- (3, 3-dimethylbutyl) pyridine compound (structural formula shown in the following formula 20):
the photocatalyst Mes-Acr-PhBF 4 (0.01 mmol,4.6 mg) and the capture reagent 2-alkenylpyridine (0.4 mmol) were weighed into oven-dried 8mL vials containing magnetic star bars. Anhydrous acetonitrile (1 mL) was added followed by linear tertiary alcohol 3, 3-dimethyl-2-phenylbutan-2-ol (0.2 mmol) and finally trifluoroacetic acid (0.4 mmol). The reaction vessel was degassed, backfilled with argon, and then placed in a SynLED x4 photoreactor (SynLED discoverTM 450 nm). The progress of the reaction was monitored by TLC. After completion, the reaction mixture was concentrated and purified by flash column chromatography on silica gel to give the desired product in 77% yield.
The results of the correlation characterization analysis are 1H NMR(500MHz,Chloroform-d)δ8.58–8.38(m,1H),7.57(td,J=7.6,1.9Hz,1H),7.15(dd,J=8.0,1.1Hz,1H),7.08(ddd,J=7.4,4.9,1.1Hz,1H),2.84–2.69(m,2H),1.67–1.54(m,2H),0.97(s,9H).13C NMR(126MHz,Chloroform-d)δ163.19,149.20,136.32,122.62,120.80,44.36,33.94,30.55,29.37.HRMS(ESI-TOF)calculated for C11H17N(M+H+):164.1434,found:164.1434.. The results further confirm that the product molecular structure is as described above for molecular structure 20.
Example 21
A process for preparing (R) - (2- (tert-butyl) -6-methoxyquinolin-4-yl) ((1S, 2S,4S, 5R) -5-vinylquinolin-2-yl) methanol compound having the structural formula shown in formula 21:
the linear tertiary alcohol is 3, 3-dimethyl-2-phenyl butane-2-alcohol, and the capturing reagent is quinine; otherwise, the same procedure as in example 11 was carried out, with a yield of 60%.
The results of the correlation characterization analysis were 1H NMR(400MHz,Chloroform-d)δ7.79(s,1H),7.66(d,J=9.2Hz,1H),6.87(dd,J=9.2,2.6Hz,1H),6.79(d,J=2.7Hz,1H),6.26(s,1H),5.86(s,1H),5.56(ddd,J=17.2,10.3,6.9Hz,1H),5.07–4.86(m,2H),4.43(s,1H),3.55(s,3H),3.37(dd,J=13.5,10.6Hz,1H),3.26(t,J=9.0Hz,1H),3.05(td,J=11.7,5.1Hz,1H),2.95(ddd,J=13.5,5.5,2.5Hz,1H),2.62(s,1H),2.30–2.15(m,1H),2.11(dd,J=13.6,7.5Hz,1H),2.04(p,J=3.2Hz,1H),1.87–1.72(m,1H),1.48(s,9H),1.37–1.28(m,1H).13C NMR(101MHz,Chloroform-d)δ165.69,157.27,143.75,143.07,137.92,131.23,123.28,121.29,116.85,115.57,99.18,66.91,60.15,56.60,55.07,43.93,37.82,37.65,30.23,27.21,24.74,18.43.HRMS(ESI-TOF)calculated for C24H32N2O2(M+H+):381.2537,found:381.2537.. This result further demonstrates that the molecular structure of the product is as described above for molecular structure 21.
The foregoing description of the preferred embodiments of the application is not intended to be limiting, but rather is intended to cover all modifications, equivalents, and alternatives falling within the spirit and principles of the application.
Claims (3)
1. A photo-redox catalytic method, comprising the steps of:
providing a linear tertiary alcohol compound and a free radical trapping agent;
carrying out catalytic reaction on the linear tertiary alcohol compound and the free radical capture reagent under the conditions of a photocatalyst and blue light;
The linear tertiary alcohol compound comprises ;
Wherein n=an integer of 0 to 4, R 1、R2 and R 3 are each independently selected from any one of C 1-C20 alkyl, C 1-C20 heteroalkyl, C 3-C20 cycloalkyl, C 3-C20 heterocycloalkyl, C 2-C20 alkenyl, C 3-C20 cycloalkenyl, C 1-C20 alkoxy, C 6-C14 aryl, C 6-C14 aryl C 1-C20 alkyl, cyano C 1-C20 alkyl, C 1-C20 alkyloxycarbonyl C 1-C20 alkyl, C 3-C20 alkylsilyl, halogen, trifluoromethoxy, sulfonamide, and hydrogen atom; and R 2 and R 3 are not hydrogen atoms;
The free radical capture reagent is at least one selected from quinoline, 2-methylquinoline, quinine, pyridine, 2, 6-lutidine, thiazole, 5-methylthiazole-4-carboxylic acid ethyl ester, benzothiazole, pyrazine, 2,3, 5-trimethylpyrazine, pyrimidine, 4, 6-dimethylpyrimidine, purine, 2, 6-dichloro-9-methyl-9H-purine;
the photocatalyst is selected from acridine salt catalyst Mes-Acr-PhBF 4;
the catalytic reaction is also added with a Bronsted acid reagent, an oxidant and an acetonitrile solvent; the bronsted acid reagent is selected from fluoroacetic acid and the oxidizing agent is selected from persulfates.
2. The photo-redox catalytic method according to claim 1, wherein R 1、R2 and R 3 are each independently selected from any of C 1-C10 alkyl, C 1-C10 heteroalkyl, C 3-C10 cycloalkyl, C 3-C10 heterocycloalkyl, C 2-C10 alkenyl, C 3-C10 cycloalkenyl, C 1-C10 alkoxy, C 6-C14 aryl, C 6-C14 aryl C 1-C10 alkyl, cyano C 1-C10 alkyl, C 1-C10 alkyloxycarbonyl C 1-C10 alkyl and C 3-C10 alkylsilyl.
3. The photo-redox catalytic process according to any one of claims 1-2, wherein the molar ratio of the photocatalyst, the oxidant and the bronsted acid reagent is (0.1-20): 0.2-40.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211378442.0A CN115710199B (en) | 2021-05-28 | 2021-05-28 | Photooxidation reduction catalytic process |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110588659.3A CN113387837B (en) | 2021-05-28 | 2021-05-28 | Photo-oxidation-reduction catalysis method |
CN202211378442.0A CN115710199B (en) | 2021-05-28 | 2021-05-28 | Photooxidation reduction catalytic process |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110588659.3A Division CN113387837B (en) | 2021-05-28 | 2021-05-28 | Photo-oxidation-reduction catalysis method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115710199A CN115710199A (en) | 2023-02-24 |
CN115710199B true CN115710199B (en) | 2024-06-28 |
Family
ID=77619330
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110588659.3A Active CN113387837B (en) | 2021-05-28 | 2021-05-28 | Photo-oxidation-reduction catalysis method |
CN202211378442.0A Active CN115710199B (en) | 2021-05-28 | 2021-05-28 | Photooxidation reduction catalytic process |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110588659.3A Active CN113387837B (en) | 2021-05-28 | 2021-05-28 | Photo-oxidation-reduction catalysis method |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN113387837B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108047230A (en) * | 2017-12-29 | 2018-05-18 | 深圳蓝新科技有限公司 | Pa Na replaces the preparation method of Buddhist nun |
CN108329240A (en) * | 2018-03-27 | 2018-07-27 | 深圳蓝新科技有限公司 | The preparation method of florfenicol midbody |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019168874A1 (en) * | 2018-02-27 | 2019-09-06 | The Research Foundation For The State University Of New York | Difluoromethoxylation and trifluoromethoxylation compositions and methods for synthesizing same |
CN109293541B (en) * | 2018-11-09 | 2020-10-27 | 闽南师范大学 | Method for preparing alpha-aryl-gamma-methylsulfinylketone compound by visible light catalysis |
-
2021
- 2021-05-28 CN CN202110588659.3A patent/CN113387837B/en active Active
- 2021-05-28 CN CN202211378442.0A patent/CN115710199B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108047230A (en) * | 2017-12-29 | 2018-05-18 | 深圳蓝新科技有限公司 | Pa Na replaces the preparation method of Buddhist nun |
CN108329240A (en) * | 2018-03-27 | 2018-07-27 | 深圳蓝新科技有限公司 | The preparation method of florfenicol midbody |
Also Published As
Publication number | Publication date |
---|---|
CN115710199A (en) | 2023-02-24 |
CN113387837A (en) | 2021-09-14 |
CN113387837B (en) | 2023-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113912577B (en) | Rockwell intermediate, rockwell and its derivative, and preparation and application | |
CN109896918B (en) | Unsaturated carbonyl compound and preparation method and application thereof | |
CN109761897B (en) | Method for copper-catalyzed alkylation of C (sp2) -H bond of N-heterocyclic aromatic hydrocarbon compound | |
CN113620762A (en) | Ketene compound and preparation method and application thereof | |
CN115710199B (en) | Photooxidation reduction catalytic process | |
CN110683926B (en) | Preparation method of carboxylic acid aryl ester compound | |
CN109912579B (en) | Preparation method of 2, 2-disubstituted tetrahydrofuran derivative | |
WO2021114424A1 (en) | Method for preparing trifluorohydrocarbyl sulfone compound | |
CN114588929A (en) | Supported copper nanocluster catalyst and application thereof in AHA coupling reaction | |
CN114773174A (en) | Synthetic method of alpha-deuterated carbonyl compound | |
CN105237466B (en) | A kind of method for synthesizing three substituted pyridine derivatives | |
JP6067700B2 (en) | Alcohol oxidation catalyst and alcohol oxidation method using the same | |
CN116444330A (en) | Addition product of alkyl free radical and capture reagent, addition method and application thereof | |
CN115745836A (en) | Method for inducing reaction of alkyl neopentyl benzene and capture reagent by photocatalyst | |
CN115872900A (en) | Method for generating and capturing alkyl free radical, product thereof and application of product | |
CN110713451B (en) | Microwave radiation-assisted synthesis method of N-methyl-2-cyano-3, 4-disubstituted pyrrole compound | |
CN112961105B (en) | Alkylation method of nitrogen-containing heterocyclic compound | |
CN109265391B (en) | Biphenyl polysubstituted 1,2,5, 6-tetrahydropyridine compound and synthetic method and application thereof | |
CN112300059B (en) | Preparation method of PF-06651600 intermediate | |
CN115433128B (en) | Acridine tetrafluoroborate photoreaction catalyst and synthesis method thereof | |
CN110938086B (en) | Half-sandwich ruthenium-thione complex and preparation method thereof, ammonia borane hydrolysis method and nitrobenzene compound reduction method | |
CN113651720B (en) | Substituted alkenyl thiocyanate compound and preparation method thereof | |
CN112125843B (en) | Preparation method of 3-hydroxymethyl-4-phenyl-3, 4-dihydroquinolinone compound | |
CN109942617B (en) | Alpha-tetra-substituted chiral alkynone compound and preparation method and application thereof | |
CN109942612B (en) | Diyne enamine compound and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant |